Myeloma News and Research

RSS
Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

Scintigraphy scan may help clinicians properly diagnose and then treat two forms of cardiac amyloidosis

Scintigraphy scan may help clinicians properly diagnose and then treat two forms of cardiac amyloidosis

Drug AMD-3100 may help cancer patients who need stem cell transplants

Drug AMD-3100 may help cancer patients who need stem cell transplants

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Breast cancer drug Herceptin soon to be widely available on NHS

Breast cancer drug Herceptin soon to be widely available on NHS

New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer

New protective drugs called bisphosphonates reduce pain and fractures in metastatic breast cancer

Curcumin has potent anticancer powers

Curcumin has potent anticancer powers

Thalidomide may be a potent anti-cancer treatment

Thalidomide may be a potent anti-cancer treatment

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

No link found between hair dyes and cancers

No link found between hair dyes and cancers

Zometa reduces bone loss in patients receiving breast cancer treatment

Zometa reduces bone loss in patients receiving breast cancer treatment

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

Vaccine developed at Rockefeller University boosts natural killer T cells in patients with cancer

National clinical trial examines new option for kidney cancer patients

National clinical trial examines new option for kidney cancer patients

Revlimid results look promising for multiple myeloma patients

Revlimid results look promising for multiple myeloma patients

Some immune cells are smarter than others killing more cancer

Some immune cells are smarter than others killing more cancer

Association noted between certain non-lver cancers and hepatitis C

Association noted between certain non-lver cancers and hepatitis C

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.